New Delhi : The approval given to two COVID-19 vaccines is a ”decisive turning point” in the spirited fight against the pandemic, Prime Minister Narendra Modi said on Sunday as the development was greeted with a sense of relief and hope in the country that has been reeling from the impact of the virus for […]
Read MoreNew Delhi: India’s drugs regulator on Sunday approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country, paving the way for a massive inoculation drive. The Drugs Controller General of India (DCGI) granted the approval on the basis of recommendations by a COVID-19 Subject Expert Committee (SEC) […]
Read MoreNew Delhi: Delhi Chief Minister Arvind Kejriwal on Sunday said that approval for the emergency use of two ”made in India” vaccines will give a positive direction to the country’s fight against coronavirus. Congratulating the countrymen, Kejriwal saluted the scientists and doctors for the achievement. The Drugs Controller General of India (DCGI) on Sunday approved Oxford COVID-19 […]
Read MoreNew Delhi: Bharat Biotech on Saturday said it is moving towards achieving the target of having 26,000 volunteers across the country for Phase-3 trials of its Covid-19 vaccine ‘Covaxin’. The company has already roped in 23,000 volunteers for the trials, it said. The company statement has come after an expert panel of India’s central drug […]
Read MoreHyderabad: Covaxin, a vaccine candidate being developed by Bharat Biotech for COVID-19, can offer protection against mutations of coronavirus, Chairman and Managing Directorof the city-based vaccine maker Krishna Ella said on Tuesday. He also said the company has approached regulatory authorities seeking approval for an emergency license to use the vaccine, developed in collaboration with the Indian Council of […]
Read More